The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Glioblastoma: Overview of Disease and Treatment
Open accessAbstract
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment options at diagnosis are multimodal and include surgical resection, radiation, and chemotherapy. Significant advances in the understanding of the molecular pathology of GBM and associated cell signaling pathways have opened opportunities for new therapies for recurrent and newly diagnosed disease. Innovative treatments, such as tumor-treating fields (TTFields) and immunotherapy, give hope for enhanced survival. OBJECTIVES: This article reviews the background, risks, common complications, and treatment options for GBM. METHODS: A brief review of GBM, treatment options, and a look at new therapies that have been approved for new and recurrent disease are included in this article. FINDINGS: Despite aggressive resection and combined modality adjuvant treatment, most GBMs recur. Treatments, such as TTFields, drugs to target molecular receptors, and immunotherapy, are promising new options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
The epidemiology of glioma in adults: a "state of the science" review
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou087 · Cited by 2,220
Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Thakkar, J. P., Dolecek, T. A., Horbinski, C., Ostrom, Q. T., Lightner, D. D., Barnholtz-Sloan, J. S., & Villano, J. L. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0275 · Cited by 1,390
Stupp, R., Taillibert, S., Kanner, A. A., Kesari, S., Steinberg, D. M., Toms, S. A., Taylor, L. P., Lieberman, F., Silvani, A., Fink, K. L., et al. (2015) · JAMA · doi:10.1001/jama.2015.16669 · Cited by 1,259
Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E. D., Taillibert, S., Liebermann, F., Dbalý, V., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.04.011 · Cited by 862
Glantz, M. J., Cole, B. F., Forsyth, P. A., Recht, L. D., Wen, P. Y., Chamberlain, M. C., Grossman, S. A., & Cairncross, J. G. (2000) · Neurology · doi:10.1212/wnl.54.10.1886 · Cited by 858
Glioblastoma multiforme: Pathogenesis and treatment
Alifieris, C., & Trafalis, D. T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.005 · Cited by 820
McGirt, M. J., Chaichana, K. L., Gathinji, M., Attenello, F. J., Than, K., Olivi, A., Weingart, J. D., Brem, H., & Quiñones-Hinojosa, A. R. (2009) · Journal of Neurosurgery · doi:10.3171/2008.4.17536 · Cited by 809
Taal, W., Oosterkamp, H. M., Walenkamp, A. M. E., Dubbink, H. J., Beerepoot, L. V., Hanse, M. C. J., Buter, J., Honkoop, A. H., Boerman, D., de Vos, F. Y. F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70314-6 · Cited by 759
Glioblastoma survival in the United States before and during the temozolomide era
Johnson, D. R., & O’Neill, B. P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0749-4 · Cited by 720
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Cohen, M. H., Shen, Y. L., Keegan, P., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0121 · Cited by 655
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
Chen, J., McKay, R. M., & Parada, L. F. (2012) · Cell · doi:10.1016/j.cell.2012.03.009 · Cited by 527
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
Keles, G. E., Anderson, B., & Berger, M. S. (1999) · Surgical Neurology · doi:10.1016/s0090-3019(99)00103-2 · Cited by 366
Glioblastoma multiforme: State of the art and future therapeutics
Harter, D., Wilson, T., & Karajannis, M. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.132138 · Cited by 327
Current trends in the surgical management and treatment of adult glioblastoma.
Young, R. M., Jamshidi, A. M., Davis, G., & Sherman, J. H. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.05.10 · Cited by 308
Kuhnt, D., Becker, A., Ganslandt, O., Bauer, M., Buchfelder, M., & Nimsky, C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor133 · Cited by 300
Radiographic patterns of relapse in glioblastoma
Chamberlain, M. C. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0251-4 · Cited by 215
Zhao, S., Wu, J., Wang, C., Liu, H., Dong, X., Shi, C., Shi, C., Liu, Y., Teng, L., Han, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063682 · Cited by 200
Image guided surgery for the resection of brain tumours
Barone, D. G., Lawrie, T. A., & Hart, M. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009685.pub2 · Cited by 183
Roder, C., Bisdas, S., Ebner, F. H., Honegger, J. B., Naegele, T., Ernemann, U., & Tatagiba, M. S. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.11.022 · Cited by 166
Medical management of brain tumors and the sequelae of treatment
Schiff, D., Lee, E. Q., Nayak, L., Norden, A. D., Reardon, D. A., & Wen, P. Y. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou304 · Cited by 161
Central Nervous System Cancers Clinical Practice Guidelines in Oncology
Brem, S. S., Bierman, P. J., Black, P. M., Blumenthal, D. T., Brem, H., Chamberlain, M. C., Chiocca, E. A., DeAngelis, L. M., Fenstermaker, R. A., Fine, H. A., et al. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0038 · Cited by 161
Prognostic Factors for Long-Term Survival after Glioblastoma
Walid, M. S. (2008) · The Permanente Journal · doi:10.7812/tpp/08-027 · Cited by 146
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Wang, H., Xu, T., Jiang, Y., Xu, H., Yan, Y., Fu, D., & Chen, J. (2015) · Neoplasia · doi:10.1016/j.neo.2015.02.002 · Cited by 145
Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations
Ellor, S. V., Pagano-Young, T. A., & Avgeropoulos, N. G. (2014) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12133 · Cited by 106
Vitucci, M., Hayes, D. N., & Miller, C. R. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606031 · Cited by 101
The effect of re-operation on survival in patients with recurrent glioblastoma.
Franceschi, E., Bartolotti, M., Tosoni, A., Bartolini, S., Sturiale, C. L., Fioravanti, A., Pozzati, E., Galzio, R. J., Talacchi, A., Volpin, L., et al. (2015) · PubMed · Cited by 66
Case-Based Review: newly diagnosed glioblastoma
Johnson, D. R., Fogh, S. E., Giannini, C., Kaufmann, T. J., Raghunathan, A., Theodosopoulos, P. V., & Clarke, J. L. (2015) · Neuro-Oncology Practice · doi:10.1093/nop/npv020 · Cited by 50
Treatment options for recurrent glioblastoma: pitfalls and future trends
Franceschi, E., Tosoni, A., Bartolini, S., Mazzocchi, V., Fioravanti, A., & Brandes, A. A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.23 · Cited by 42
Complications of Brain Tumors and Their Treatment
Lacy, J., Saadati, H., & Yu, J. B. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.04.007 · Cited by 42
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Niyazi, M., Harter, P. N., Hattingen, E., Rottler, M., von Baumgarten, L., Proescholdt, M. A., Belka, C., Lauber, K., & Mittelbronn, M. G. A. (2015) · Oncotarget · doi:10.18632/oncotarget.6320 · Cited by 40
Glioblastoma Multiforme: Enhancing Survival and Quality of Life
Davis, M. E., & Stoiber, A. (2011) · Clinical journal of oncology nursing · doi:10.1188/11.cjon.291-297 · Cited by 38
Self-citationMedical Management of Patients With Brain Tumors
Pruitt, A. A. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464172.50638.21 · Cited by 28
Imaging Genomics of Glioblastoma: Biology, Biomarkers, and Breakthroughs
Moton, S., Elbanan, M., Zinn, P. O., & Colen, R. R. (2015) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000052 · Cited by 18
Glioblastoma: Part I. Current state of affairs.
Salacz, M. E., Watson, K. R., & Schomas, D. A. (2011) · Europe PMC (PubMed Central) · Cited by 16
Impact of Extent of Resection on Outcomes in Patients with High-Grade Gliomas
Mukherjee, D. R., & Quiñones‐Hinojosa, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0618-7_19 · Cited by 8
Tumor Treating Fields—An Emerging Cancer Treatment Modality
Davis, M. E. (2013) · Clinical journal of oncology nursing · doi:10.1188/13.cjon.441-443 · Cited by 7
Self-citation
Cited by
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
Challenges and Opportunities in Cancer Drug Resistance
Ward, R. A., Fawell, S., Floc’h, N., Flemington, V., McKerrecher, D., & Smith, P. D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00383 · Cited by 445
Nanocarrier-based drug combination therapy for glioblastoma
Zhao, M., van Straten, D., Broekman, M. L. D., Préat, V., & Schiffelers, R. M. (2020) · Theranostics · doi:10.7150/thno.38147 · Cited by 373
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Taylor, O. G., Brzozowski, J. S., & Skelding, K. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00963 · Cited by 322
Metadata
- Authors
- Davis, M.
- Venue
- Clinical Journal of Oncology Nursing
- Publisher
- Oncology Nursing Society (ONS)
- Published
- 2016-10-01
- Volume
- 20
- Issue
- 5
- Pages
- S2-S8
- ISSN
- 1092-1095 (ISSN-L)
- 1538-067X
- OpenAlex
- W2526011086
- Cited by
- 1,205
- References
- 49
- FWCI
- 31.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.